ProQR Therapeutics N.V. (PRQR) Live Share Price, Invest From India

ProQR Therapeutics N.V. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.67
Day's Price Range
$1.97
$1.89
11.64%
Downside
4.23%
Upside
52 Week's Low
52 Week's High
$1.33
52-Week Price Range
$3.10
$1.89
29.63%
Downside
64.02%
Upside

ProQR Therapeutics N.V. share price movements today

Previous Close: $1.67
Open: $1.67
Volume: 1.9M
Day's Low - High: $1.67 - $1.97
52 Week Low - High: $1.33 - $3.10

ProQR Therapeutics N.V. Historical Returns

1 Month Return: + 32.17 %
3 Month Return: + 18.87 %
1 Year Return: -2.58 %
3 Year Return: + 7.39 %
5 Year Return: -75.1 %

ProQR Therapeutics N.V. Stock Fundamentals & Key Indicators

Check ProQR Therapeutics N.V. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$176.0M

EPS (TTM)

-0.616

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-45.4M

Revenue (TTM)

13.6M

Profit Margin

0.00%

Return On Equity TTM

-78.07%

ProQR Therapeutics N.V. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProQR Therapeutics N.V. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
ProQR Therapeutics N.V.	BUY	$176.0M	-75.1%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for ProQR Therapeutics N.V. Stock including INR - Dollar returns

The ProQR Therapeutics N.V. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

ProQR Therapeutics N.V. investment value today

Current value as on today

₹1,06,121

Returns

₹6,121

(+6.12%)

Returns from ProQR Therapeutics N.V. Stock

-₹2,577 (-2.58%)

Dollar Impact

₹8,698 (+8.7%)

Analyst Recommendation on ProQR Therapeutics N.V. Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for ProQR Therapeutics N.V.. Average target price of $8.88

ProQR Therapeutics N.V. Share Price Target

Get share price movements and forecasts by analysts on ProQR Therapeutics N.V..

What analysts predicted

78.72%UPSIDE

Target Price

$8.88

Current Price

$1.89

Analyzed by

13 Analysts

Target

$8.88

ProQR Therapeutics N.V. target price $8.88, a slight upside of 78.72% compared to current price of $1.89. According to 13 analysts rating.

Indian Investors' Interest in ProQR Therapeutics N.V. Stock

Search interest for ProQR Therapeutics N.V. Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:-28% versus previous 30 day period

ProQR Therapeutics N.V. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	3	4	6	4	4	4	3	2	4	2
Gross Profit	3	4	6	4	4	4	3	2	3	1
Operating Income	-6	-8	-3	-8	-10	-10	-12	-11	-9	-13
EBITDA	0	-6	-2	-8	-5	-9	-11	-10	-8	-12
Interest Expense	0	0	0	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-7	-2	-8	-9	-10	-12	-11	-8	-13
Income Tax Expense	0	0	0	-	-	-	0	-	0	0
Net Income	-5	-8	-2	-9	-9	-10	-12	-11	-8	-13
Net Profit Margin	-166.96%	-172.09%	-42.70%	-210.98%	-216.04%	-223.04%	-319.07%	-377.56%	-190.27%	-658.29%

ProQR Therapeutics N.V. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	2	-1	5	2	1	1	3	7	19	15
Gross Profit	1	-2	4	-127	1	1	3	7	19	12
Operating Income	-39	-40	-36	-57	-42	-57	-65	-31	-30	-42
EBITDA	-120	-40	-35	-174	-48	-54	-56	-24	-24	-37
Interest Expense	0	0	0	1	2	3	5	1	1	0
Depreciation	-	1	0	2	2	2	2	2	2	2
Income Before Tax	-39	-43	-37	-56	-46	-60	-64	-27	-27	-40
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-41	-51	-41	-63	-56	-68	-68	-30	-29	-40
Net Profit Margin	-1713.54%	2853.96%	-746.69%	-2935.64%	-4525.27%	-4549.81%	-1792.54%	-431.67%	-146.86%	-265.21%

ProQR Therapeutics N.V. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-2	-8	-9	-10	-12	-11	-8	-13
Operating Cash Flow	-15	-6	-5	-9	-15	-11	-12	-13	-11
Investing Cash Flow	-17	0	16	-2	0	0	0	0	0
Financing Cash Flow	0	0	0	71	0	0	0	0	0
Change in Cash	-33	-6	10	60	-16	-12	-12	-14	-13

ProQR Therapeutics N.V. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-43	-37	-56	-46	-60	-64	-27	-27	-40
Operating Cash Flow	-34	-30	-43	-47	-26	-68	21	-36	-50
Investing Cash Flow	0	0	0	0	0	0	4	-4	0
Financing Cash Flow	26	88	50	14	136	-30	-2	70	-1
Change in Cash	-11	57	6	-36	111	-92	24	30	-39

Global Institutional Holdings in ProQR Therapeutics N.V.

Funds	Holdings
Citadel Advisors Llc	0.67%
M28 Capital Management LP	0.57%
Aberdeen Group PLC	3.15%
Dafna Capital Management LLC	1.49%
Ikarian Capital, LLC	1.42%

See all

Insights on ProQR Therapeutics N.V.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, PRQR stock has moved up by 31.3%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, PRQR has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 21.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -8.83M → -13.60M (in $), with an average decrease of 53.9% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 4.64M → 2.06M (in $), with an average decrease of 55.5% per quarter

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

Organisation	ProQR Therapeutics N.V.
Headquarters	Zernikedreef 9, Leiden, Netherlands, 2333 CK
Industry	Biotechnology
CEO	Mr. Daniel Anton de Boer
E-voting on shares	Click here to vote

Key Management of ProQR Therapeutics N.V.

Name	Title
Mr. Daniel Anton de Boer	Founder, CEO & Executive Director
Dr. Gerard Platenburg Ph.D.	Co-Founder, Chief Scientific Officer & Executive Director
Mr. Dennis Hom	Chief Financial Officer
Ms. Sheila Sponselee	Chief People & Operations Officer
Ms. Sarah Cue Kiely	Vice President of Investor Relations & Corporate Communications
Dr. Cristina Lopez Lopez M.D., Ph.D.	Chief Medical Officer
Ms. Sandra van der Kolk	Junior Financial Controller

FAQs

What is ProQR Therapeutics N.V. share price today?

ProQR Therapeutics N.V. share price today is $1.89 as on June 19, 2026 at 8:45 am IST at the close of the market. ProQR Therapeutics N.V. share today touched a day high of $1.97 and a low of $1.67.

What is the 52 week high and 52 week low for ProQR Therapeutics N.V. share?

ProQR Therapeutics N.V. share touched a 52 week high of $3.1 on October 21, 2025 and a 52 week low of $1.33 on February 12, 2026. ProQR Therapeutics N.V. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $1.89,which is 39.03% down from its 52 week high and 42.11% up from its 52 week low.

What is ProQR Therapeutics N.V.'s market capitalisation today?

ProQR Therapeutics N.V. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in ProQR Therapeutics N.V. Stock (PRQR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ProQR Therapeutics N.V. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ProQR Therapeutics N.V. Shares that will get you 0.7937 shares as per ProQR Therapeutics N.V. share price of $1.89 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy ProQR Therapeutics N.V. Stock (PRQR) from India?

Indian investors can start investing in ProQR Therapeutics N.V. (PRQR) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 8:59 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in ProQR Therapeutics N.V. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 8:59 pm IST). Based on ProQR Therapeutics N.V. share’s latest price of $1.89 as on June 19, 2026 at 8:45 am IST, you will get 5.2910 shares of ProQR Therapeutics N.V.. Learn more about fractional shares .

What are the returns that ProQR Therapeutics N.V. has given to Indian investors in the last 5 years?

ProQR Therapeutics N.V. stock has given -75.1% share price returns and 27.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?